We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPH
826
DELISTED
scPharmaceuticals
SCPH
$637K 0.01%
132,200
– –
ASYS icon
827
Amtech Systems
ASYS
$262M
$634K 0.01%
86,800
– –
NWFL icon
828
Norwood Financial Corp
NWFL
$370M
$633K 0.01%
26,112
– –
PFHD
829
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$632K 0.01%
31,500
– –
EPM icon
830
Evolution Petroleum
EPM
$127M
$624K 0.01%
114,300
-25,000
-18% -$168K
CNCE
831
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$624K 0.01%
148,200
+55,000
+59% +$218K
HRTG icon
832
Heritage Insurance Holdings
HRTG
$1.07B
$623K 0.01%
236,100
– –
LCTX icon
833
Lineage Cell Therapeutics
LCTX
$282M
$623K 0.01%
394,366
+379,700
+2,589% +$501K
ISSC icon
834
Innovative Solutions & Support
ISSC
$367M
$618K 0.01%
85,800
– –
SBFM
835
Sunshine Biopharma
SBFM
$3.33M
$614K 0.01%
+28
New +$1.37M
PBIP
836
DELISTED
Prudential Bancorp, Inc.
PBIP
$614K 0.01%
40,557
– –
SCX
837
DELISTED
The L.S. Starrett Company
SCX
$613K 0.01%
87,311
– –
CRMD icon
838
CorMedix
CRMD
$589M
$611K 0.01%
151,900
-18,400
-11% -$68.4K
SGMA
839
DELISTED
Sigmatron International
SGMA
$610K 0.01%
86,415
+1,000
+1% +$6.57K
NCSM icon
840
NCS Multistage Holdings
NCSM
$128M
$602K 0.01%
19,687
+92
+0.5% +$3.84K
CPIX icon
841
Cumberland Pharmaceuticals
CPIX
$115M
$595K 0.01%
286,655
– –
MTNB icon
842
Matinas BioPharma
MTNB
$1.72M
$595K 0.01%
15,068
– –
STRR
843
Star Equity Holdings
STRR
$42.4M
$593K 0.01%
18,880
+4,200
+29% +$149K
ELF icon
844
e.l.f. Beauty
ELF
$5.44B
$589K 0.01%
19,200
– –
SVRA icon
845
Savara
SVRA
$1.19B
$588K 0.01%
386,793
– –
NXTC icon
846
NextCure
NXTC
$22.7M
$586K 0.01%
10,392
-833
-7% -$43.5K
PHX
847
DELISTED
PHX Minerals
PHX
$585K 0.01%
192,350
-21,600
-10% -$75.7K
OMCC
848
DELISTED
Old Market Capital Corp
OMCC
$585K 0.01%
62,800
– –
MCBS icon
849
MetroCity Bankshares
MCBS
$1.03B
$583K 0.01%
28,700
– –
CRWS icon
850
Crown Crafts
CRWS
$32.3M
$580K 0.01%
92,700
– –
32 33
34
35 36

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.